Trial · NCT03128411
Results by group161
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 161
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Major Molecular Response (MMR) at Month 12 | Bosutinib | 55.0 | 90% Confidence Interval 44.4 to 65.6 | Percentage of participants | |
| Percentage of Participants With Major Molecular Response (MMR) by Month 12 | Bosutinib | 61.7 | 90% Confidence Interval 51.3 to 72.0 | Percentage of participants | |
| Percentage of Participants With Major Molecular Response (MMR) by Month 18 | Bosutinib | 66.7 | 90% Confidence Interval 56.7 to 76.7 | Percentage of participants | |
| Percentage of Participants With Complete Cytogenetic Response (CCyR) by Month 12 | Bosutinib | 80.0 | 90% Confidence Interval 71.5 to 88.5 | Percentage of participants | |
| Probability of Maintaining Major Molecular Response (MMR) at Month 36 | Bosutinib | 100.0 | 90% Confidence Interval 100.0 to 100.0 | Percentage of participants | |
| Probability of Maintaining Complete Cytogenetic Response (CCyR) at Month 36 | Bosutinib | 100.0 | 90% Confidence Interval 100.0 to 100.0 | Percentage of participants | |
| Cumulative Incidence of Event Free Survival (EFS) at Month 36 | Bosutinib | 1.7 | 90% Confidence Interval 0.2 to 6.4 | Percentage of participants | |
| Probability of Overall Survival (OS) at Month 36 | Bosutinib | 96.7 | 90% Confidence Interval 89.7 to 98.9 | Percentage of participants | |
| Trough Plasma Concentrations of Bosutinib | Bosutinib | Day 1 | 0.000 | Standard Deviation 0.000 | Nanogram per milliliter (ng/mL) |
| Trough Plasma Concentrations of Bosutinib | Bosutinib | Day 28 | 83.564 | Standard Deviation 64.1056 | Nanogram per milliliter (ng/mL) |
| Trough Plasma Concentrations of Bosutinib | Bosutinib | Day 56 | 85.963 | Standard Deviation 46.4095 | Nanogram per milliliter (ng/mL) |
| Trough Plasma Concentrations of Bosutinib | Bosutinib | Day 84 | 79.659 | Standard Deviation 41.5369 | Nanogram per milliliter (ng/mL) |
| Summary and Analysis of Trough Bosutinib Plasma Concentration by Major Molecular Response (MMR) Response | Bosutinib | Yes: Day 28 | 94.943 | Standard Deviation 71.9332 | ng/mL |
| Summary and Analysis of Trough Bosutinib Plasma Concentration by Major Molecular Response (MMR) Response | Bosutinib | No: Day 28 | 59.770 | Standard Deviation 35.4568 | ng/mL |
| Summary and Analysis of Trough Bosutinib Plasma Concentration by Major Molecular Response (MMR) Response | Bosutinib | Yes: Day 56 | 88.196 | Standard Deviation 48.9671 | ng/mL |
| Summary and Analysis of Trough Bosutinib Plasma Concentration by Major Molecular Response (MMR) Response | Bosutinib | No: Day 56 | 82.092 | Standard Deviation 42.9741 | ng/mL |
| Summary and Analysis of Trough Bosutinib Plasma Concentration by Major Molecular Response (MMR) Response | Bosutinib | Yes: Day 84 | 81.339 | Standard Deviation 41.5443 | ng/mL |
| Summary and Analysis of Trough Bosutinib Plasma Concentration by Major Molecular Response (MMR) Response | Bosutinib | No: Day 84 | 75.654 | Standard Deviation 42.9290 | ng/mL |
| Summary and Analysis of Trough Bosutinib Plasma Concentration by CCyR Response | Bosutinib | Yes: Day 28 | 87.006 | Standard Deviation 64.1820 | ng/mL |
| Summary and Analysis of Trough Bosutinib Plasma Concentration by CCyR Response | Bosutinib | No: Day 28 | 28.490 | Standard Deviation 38.3393 | ng/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03128411/results